ASSESSING THE COST-UTILITY OF ETELCALCETIDE: A MARKOV MODEL

被引：0
|
作者：
Stollenwerk, B. [1 ]
Iannazzo, S. [2 ]
Akehurst, R. [3 ]
Adena, M. [4 ]
Briggs, A. [5 ]
Dehmel, B. [6 ]
Parfrey, P. [7 ]
Belozeroff, V [6 ]
机构：
[1] Amgen Europe GmbH, Zug, Switzerland
[2] SIHS SRL, Turin, Italy
[3] BresMed Hlth Solut, Sheffield, S Yorkshire, England
[4] Datalyt Pty Ltd, Bruce, ACT, Australia
[5] Univ Glasgow, Glasgow, Lanark, Scotland
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
[7] Mem Univ, St John, NF, Canada
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK18
引用
收藏
页码：A519 / A519
页数：1
相关论文
共 50 条
  • [1] Assessing the cost-utility of psoriasis therapies
    Weiss, S
    Kimball, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P177 - P177
  • [2] A DECISION ANALYTIC MARKOV MODEL TO COMPARE THE COST-UTILITY OF TVT VERSUS DULOXETINE
    Renganathan, A.
    Duckett, J. R.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2009, 20 : S217 - S218
  • [3] Assessing Health Gains: A Cost-Utility Analysis
    Guarducci, G.
    Siragusa, C.
    Gurnari, J.
    Gentile, A. M.
    Nante, N.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [4] Decision tree-Markov model of perinatal depression screening: a cost-utility analysis
    Yang, Yehuan
    Zheng, Ruimin
    Yang, Li
    Huang, Xing
    Zhang, Tong
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [5] Cost-utility analysis of orthoptic screening in kindergarten:: A Markov model based on data from Germany
    König, HH
    Barry, JC
    PEDIATRICS, 2004, 113 (02) : 95 - 108
  • [6] Medical or surgical therapy for erosive reflux esophagitis - Cost-utility analysis using a Markov model
    Romagnuolo, J
    Meier, MA
    Sadowski, DC
    ANNALS OF SURGERY, 2002, 236 (02) : 191 - 202
  • [7] The cost-utility of school-based first permanent molar sealants programs: a Markov model
    Espinoza-Espinoza, Gerardo
    Corsini, Gilda
    Rojas, Ruben
    Marino, Rodrigo
    Zaror, Carlos
    BMC ORAL HEALTH, 2019, 19 (01)
  • [8] A MARKOV COST-UTILITY MODEL ON THE PROVISION OF ERYTHROPOIETIN (EPO) FOR CHRONIC-HEMODIALYSIS (HD) PATIENTS
    MANALICH, J
    GOEL, V
    CHURCHILL, DN
    MEDICAL DECISION MAKING, 1991, 11 (04) : 323 - 323
  • [9] The cost-utility of school-based first permanent molar sealants programs: a Markov model
    Gerardo Espinoza-Espinoza
    Gilda Corsini
    Rubén Rojas
    Rodrigo Mariño
    Carlos Zaror
    BMC Oral Health, 19
  • [10] A COST-UTILITY MODEL FOR RENAL TRANSPLANTS IN COLOMBIA
    Rosselli, D.
    VALUE IN HEALTH, 2009, 12 (07) : A484 - A484
12345